Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 3, 2015, Pages 716-724

  Kunutsor, Setor K ^a,b   Bakker, Stephan J L ^c   Gansevoort, Ronald T ^c   Chowdhury, Rajiv ^a   Dullaart, Robin P F ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Department of Nephrology Medicine ^*  (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cardiovascular diseases; meta analysis; risk factors

Indexed keywords

BILIRUBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROSPECTIVE STUDY; REYNOLDS RISK SCORE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; CARDIOVASCULAR DISEASES; INCIDENCE; META ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGED; BILIRUBIN; BIOMARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84920885504     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304929     Document Type: Article

References (42)

1. Vítek L, The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol 2012 3 55. doi: 10.3389/fphar.2012.00055
2. Green RM, Flamm S, AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002 123 1367 1384
3. Djoussé L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC, Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001 87 1196 200; A4, 7
4. Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G, Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 2001 154 747 754
5. Kimm H, Yun JE, Jo J, Jee SH, Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009 40 3422 3427. doi: 10.1161/STROKEAHA.109.560649
6. Horsfall LJ, Nazareth I, Petersen I, Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 2012 126 2556 2564. doi: 10.1161/CIRCULATIONAHA.112.114066
7. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR, Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996 16 250 255
8. Schwertner HA, Jackson WG, Tolan G, Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994 40 18 23
9. Vítek L, Jirsa M, Brodanová M, Kalab M, Marecek Z, Danzig V, Novotný L, Kotal P, Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002 160 449 456
10. Chen YH, Hung SC, Tarng DC, Serum bilirubin links UGT1A1∗28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients. Clin J Am Soc Nephrol 2011 6 567 574. doi: 10.2215/CJN.06130710
11. Schooling CM, Kelvin EA, Jones HE, Alanine transaminase has opposite associations with death from diabetes and ischemic heart disease in NHANES III. Ann Epidemiol 2012 22 789 798. doi: 10.1016/j.annepidem.2012.08.003
12. Temme EH, Zhang J, Schouten EG, Kesteloot H, Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 2001 12 887 894
13. Novotný L, Vítek L, Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 2003 228 568 571
14. Seppen J, Bosma P, Bilirubin, the gold within. Circulation 2012 126 2547 2549. doi: 10.1161/CIRCULATIONAHA.112.147082
15. Schwertner HA, Fischer JR Jr, Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease. Atherosclerosis 2000 150 381 387
16. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG, Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995 41 1504 1508
17. Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrières J, Ducimetière P, Patterson CC, Kee F, Yarnell JW, Evans A, PRIME Study Group Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil 2007 14 79 84. doi: 10.1097/01.hjr.0000230097.81202.9f
18. Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA, Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med 2008 121 781 788 e1
19. Barrett PV, Hyperbilirubinemia of fasting. JAMA 1971 217 1349 1353
20. Stender S, Frikke-Schmidt R, Nordestgaard BG, Grande P, Tybjaerg-Hansen A, Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis. J Intern Med 2013 273 59 68. doi: 10.1111/j.1365-2796.2012.02576.x
21. Schwertner HA, Vítek L, Gilbert syndrome, UGT1A1∗28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008 198 1 11. doi: 10.1016/j.atherosclerosis.2008.01.001
22. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F, Association between the UGT1A1∗28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006 114 1476 1481. doi: 10.1161/CIRCULATIONAHA.106.633206
23. Vítek L, Schwertner HA, The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007 43 1 57
24. McArdle PF, Whitcomb BW, Tanner K, Mitchell BD, Shuldiner AR, Parsa A, Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference. BMC Cardiovasc Disord 2012 12 16. doi: 10.1186/1471-2261-12-16
25. Keavney B, Genetic epidemiological studies of coronary heart disease. Int J Epidemiol 2002 31 730 736
26. Petitti DB, Freedman DA, Invited commentary: how far can epidemiologists get with statistical adjustment? Am J Epidemiol 2005 162 415 418; discussion 419. doi: 10.1093/aje/kwi224
27. Bruckert E, Labreuche J, Amarenco P, Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis 2010 210 353 361. doi: 10.1016/j.atherosclerosis.2009.12.023
28. Davey Smith G, Ebrahim S, 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003 32 1 22
29. Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A, Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease. JAMA Intern Med 2013 173 1222 1228. doi: 10.1001/jamainternmed.2013.6465
30. Burgess S, Thompson SG, Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol 2013 42 1134 1144. doi: 10.1093/ije/dyt093
31. Pierce BL, Ahsan H, Vanderweele TJ, Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 2011 40 740 752. doi: 10.1093/ije/dyq151
32. Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JA, Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 2012 21 223 242. doi: 10.1177/0962280210394459
33. Targher G, Risk of ischemic stroke and decreased serum bilirubin levels: is there a causal link? Arterioscler Thromb Vasc Biol 2014 34 702 704. doi: 10.1161/ATVBAHA.114.303279
34. McCarty MF, "Iatrogenic Gilbert syndrome"-A strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypotheses 2007 69 974 994. doi: 10.1016/j.mehy.2006.12.069
35. Peterson SJ, Frishman WH, Abraham NG, Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiol Rev 2009 17 99 111. doi: 10.1097/CRD.0b013e31819d813a
36. Li RY, Cao ZG, Zhang JR, Li Y, Wang RT, Decreased serum bilirubin is associated with silent cerebral infarction. Arterioscler Thromb Vasc Biol 2014 34 946 951. doi: 10.1161/ATVBAHA.113.303003
37. Franchini M, Targher G, Lippi G, Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons? Adv Clin Chem 2010 50 47 63
38. Koeth RA, Wang Z, Levison BS, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013 19 576 585. doi: 10.1038/nm.3145
39. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, Breteler MM, Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002 51 285 289
40. Ong KL, Allison MA, Cheung BM, Wu BJ, Barter PJ, Rye KA, The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004. PLoS One 2014 9 e94479. doi: 10.1371/journal.pone.0094479
41. Deetman PE, Bakker SJ, Kwakernaak AJ, Navis G, Dullaart RP, PREVEND Study Group The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects. PLoS One 2014 9 e90886. doi: 10.1371/journal.pone.0090886
42. Lin H, Yu CH, Jen CY, Cheng CF, Chou Y, Chang CC, Juan SH, Adiponectin-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPARα dependent mechanism. Am J Pathol 2010 177 1697 1709. doi: 10.2353/ajpath.2010.090789